Clinical Trial Update: Phase II Trial of Ontak With Metastatic Melanoma [Phase 2]

View source ↗

Summary

Phase II trial evaluating Ontak (denileukin diftitox) in metastatic melanoma has completed, with results posted in 2014. The update summarizes the outcomes of t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• ONTAK (denileukin diftitox)

Snippet

Sponsor: James Graham Brown Cancer Center | Conditions: Malignant Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2014-09-05